New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

by Impact Journals LLCCombined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02. Credit: 2024 Booth et al.A new research paper titled "GZ17-6
Oncology May 26,2024
GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

by Impact Journals LLCCombined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02. Credit: 2024 Booth et al.A new research paper titled "GZ17-6
Oncology May 26,2024
Ketamine's promise for severe depression grows, but major questions remain

Ketamine's promise for severe depression grows, but major questions remain

by University of MichiganCredit: CC0 Public DomainUsing an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few year
Oncology May 26,2024
Ketamine's promise for severe depression grows, but major questions remain

Ketamine's promise for severe depression grows, but major questions remain

by University of MichiganCredit: CC0 Public DomainUsing an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few year
Oncology May 26,2024
Here's why some high-risk patients aren't getting drugs to combat COVID

Here's why some high-risk patients aren't getting drugs to combat COVID

by Emily Alpert Reyes, Los Angeles TimesCredit: Unsplash/CC0 Public DomainAs the toll from the COVID-19 pandemic continued to mount, antiviral medications such as Paxlovid were hailed by health offici
Oncology May 26,2024
Here's why some high-risk patients aren't getting drugs to combat COVID

Here's why some high-risk patients aren't getting drugs to combat COVID

by Emily Alpert Reyes, Los Angeles TimesCredit: Unsplash/CC0 Public DomainAs the toll from the COVID-19 pandemic continued to mount, antiviral medications such as Paxlovid were hailed by health offici
Oncology May 26,2024
Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

by IOS PressSkeletal muscle fibers. Credit: Berkshire Community College Bioscience Image Library / Public domainThe drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duch
Oncology May 26,2024
Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

by IOS PressSkeletal muscle fibers. Credit: Berkshire Community College Bioscience Image Library / Public domainThe drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duch
Oncology May 26,2024
Is cold water bad for you? What about drinking from the hose or tap? The facts behind five water myths

Is cold water bad for you? What about drinking from the hose or tap? The facts behind five water myths

by Oliver A.H. Jones,The ConversationCredit: Unsplash/CC0 Public DomainWe know theimportance of staying hydrated, especially in hot weather. But even for something as simple as a drink of
Oncology May 26,2024
Is cold water bad for you? What about drinking from the hose or tap? The facts behind five water myths

Is cold water bad for you? What about drinking from the hose or tap? The facts behind five water myths

by Oliver A.H. Jones,The ConversationCredit: Unsplash/CC0 Public DomainWe know theimportance of staying hydrated, especially in hot weather. But even for something as simple as a drink of
Oncology May 26,2024
Researchers test previously approved FDA drugs to treat Lowe syndrome

Researchers test previously approved FDA drugs to treat Lowe syndrome

by Purdue UniversityR. Claudio Aguilar, a Purdue University researcher, has developed a patented therapeutic strategy for Lowe syndrome by repurposing two drugs previously approved by the U.S. Fo
Oncology May 26,2024
Researchers test previously approved FDA drugs to treat Lowe syndrome

Researchers test previously approved FDA drugs to treat Lowe syndrome

by Purdue UniversityR. Claudio Aguilar, a Purdue University researcher, has developed a patented therapeutic strategy for Lowe syndrome by repurposing two drugs previously approved by the U.S. Fo
Oncology May 26,2024
Viagra could help treat oxygen-deprived newborns, clinical trial finds

Viagra could help treat oxygen-deprived newborns, clinical trial finds

by McGill University Health CentreEvolution over time of brain MRI of 2 neonates with NE with severe near-total brain injury despite TH, when treated with TH and placebo (top) and when treated wi
Oncology May 26,2024
Viagra could help treat oxygen-deprived newborns, clinical trial finds

Viagra could help treat oxygen-deprived newborns, clinical trial finds

by McGill University Health CentreEvolution over time of brain MRI of 2 neonates with NE with severe near-total brain injury despite TH, when treated with TH and placebo (top) and when treated wi
Oncology May 26,2024
Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

by University of LiverpoolCredit: Unsplash/CC0 Public DomainA research paper published today inThe Lancet Oncologydemonstrates that the drug enobosarm, a selective androgen receptor m
Oncology May 26,2024
Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

by University of LiverpoolCredit: Unsplash/CC0 Public DomainA research paper published today inThe Lancet Oncologydemonstrates that the drug enobosarm, a selective androgen receptor m
Oncology May 26,2024
Milestone rating system improved residency knowledge ratings bias

Milestone rating system improved residency knowledge ratings bias

by Elana GotkineAdoption of the Milestone ratings system in 2014 was associated with improvement in internal medicine (IM) residency knowledge ratings bias in Black or Latino residents, who are underr
Oncology May 26,2024
Milestone rating system improved residency knowledge ratings bias

Milestone rating system improved residency knowledge ratings bias

by Elana GotkineAdoption of the Milestone ratings system in 2014 was associated with improvement in internal medicine (IM) residency knowledge ratings bias in Black or Latino residents, who are underr
Oncology May 26,2024
Researcher advances novel therapeutic agent for hemorrhagic stroke

Researcher advances novel therapeutic agent for hemorrhagic stroke

by Tyrel Linkhorn,University of ToledoCofilin signaling, including upstream and downstream pathways affected by secondary injury after ICH. Molecular changes impact motor and post-stroke cogniti
Oncology May 26,2024
Researcher advances novel therapeutic agent for hemorrhagic stroke

Researcher advances novel therapeutic agent for hemorrhagic stroke

by Tyrel Linkhorn,University of ToledoCofilin signaling, including upstream and downstream pathways affected by secondary injury after ICH. Molecular changes impact motor and post-stroke cogniti
Oncology May 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com